Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral Regimens
This study has been completed.
Information provided by (Responsible Party):
University of California, San Francisco
First received: October 30, 2009
Last updated: November 20, 2012
Last verified: November 2012
The study is recruiting 50 patients initiating or switching to Atripla and comparing them to 250 individuals previously followed in a prospective study of HIV+ low income individuals recruited from homeless shelters, single room occupancy hotels and free meal food lines as part of the UCSF Reach Study. Adherence will be measured through monthly unannounced pill counts and electronic medication monitors.
||Observational Model: Cohort
Time Perspective: Prospective
||Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral Regimens
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||June 2008 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
HIV infected, marginally housed
- 18+ years old;
- Initiating Atripla within 6-months of recruitment;
- Lives in the Tenderloin, South of Market, or Mission District San Francisco;
- Capable of providing informed consent; and
- Willing to complete all study procedures.
- Intoxication, cognitive dysfunction or psychosis will preclude potential subjects from informed consent.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
No Contacts or Locations Provided
No publications provided
||University of California, San Francisco
History of Changes
|Other Study ID Numbers:
|Study First Received:
||October 30, 2009
||November 20, 2012
||United States: Institutional Review Board
Keywords provided by University of California, San Francisco:
ClinicalTrials.gov processed this record on March 02, 2015